New guidelines issued for pediatric fever and neutropenia

September 19, 2012
New guidelines issued for pediatric fever and neutropenia
New evidence-based guidelines have been compiled on the management of fever and neutropenia in children with cancer and/or who are undergoing hematopoietic stem-cell transplantation; the guidelines were published online Sept. 17 in the Journal of Clinical Oncology.

(HealthDay)—New evidence-based guidelines have been compiled on the management of fever and and neutropenia (FN) in children with cancer and/or who are undergoing hematopoietic stem-cell transplantation; the guidelines were published online Sept. 17 in the Journal of Clinical Oncology.

Thomas Lehrnbecher, M.D., of the Johann Wolfgang Goethe University in Frankfurt, Germany, and colleagues from the International Pediatric Fever and Neutropenia Guideline Panel followed validated procedures to create evidence-based guidelines for the management of FN in children with cancer and/or undergoing hematopoietic stem-cell transplantation.

Based on the evidence in the literature, summaries were compiled and the evidence graded. The panel made recommendations in the following areas: initial presentation, including , initial evaluation, and treatment; ongoing management, which included cessation of empiric antibiotics; and empiric antifungal treatment for FN, comprising risk stratification, assessment, and treatment.

"This guideline represents an evidence-based approach to FN specific to children with cancer," the authors write. "Although some recommendations are similar to adult-based guidelines, there are key distinctions in multiple areas. Implementation will require adaptation to the local context."

Several authors disclosed to the pharmaceutical industry.

Explore further: New harmonized cardiovascular treatment guidelines make heart disease treatment easier

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

New harmonized cardiovascular treatment guidelines make heart disease treatment easier

September 12, 2011
A new set of harmonized guidelines for the management of risk factors for cardiovascular disease will make it much easier for physicians to care for their patients, according to the authors of the C-CHANGE guidelines published ...

Full weight-Based chemo doses recommended for obese

April 6, 2012
(HealthDay) -- The American Society of Clinical Oncology Clinical Practice Guideline on Appropriate Chemotherapy Dosing for Obese Adult Patients With Cancer recommends using full weight-based cytotoxic chemotherapy doses ...

DMP for diabetes type 2: Current guidelines indicate some need for revision

January 3, 2012
On 3 January 2012, the German Institute for Quality and Efficiency in Health Care (IQWiG) published the results of a literature search for evidence-based clinical practice guidelines on the treatment of people with diabetes ...

IU analysis changing diagnosis and management of initial UTIs in young children

August 30, 2011
Analysis by Indiana University School of Medicine researchers of ten years of scientific studies has resulted in changes in American Academy of Pediatrics recommendations for how initial urinary tract infection in infants ...

Recommended for you

New approach attacks 'undruggable' cancers from the outside in

January 23, 2018
Cancer researchers have made great strides in developing targeted therapies that treat the specific genetic mutations underlying a patient's cancer. However, many of the most common cancer-causing genes are so central to ...

Study: Cells of three advanced cancers die with drug-like compounds that reverse chemo failure

January 23, 2018
Researchers at Southern Methodist University have discovered three drug-like compounds that successfully reverse chemotherapy failure in three of the most commonly aggressive cancers—ovarian, prostate and breast.

'Hijacker' drives cancer in some patients with high-risk neuroblastoma

January 23, 2018
Researchers have identified mechanisms that drive about 10 percent of high-risk neuroblastoma cases and have used a new approach to show how the cancer genome "hijacks" DNA that regulates other genes. The resulting insights ...

Enzyme inhibitor combined with chemotherapy delays glioblastoma growth

January 23, 2018
In animal experiments, a human-derived glioblastoma significantly regressed when treated with the combination of an experimental enzyme inhibitor and the standard glioblastoma chemotherapy drug, temozolomide.

Researchers identify a protein that keeps metastatic breast cancer cells dormant

January 23, 2018
A study headed by ICREA researcher Roger Gomis at the Institute for Research in Biomedicine (IRB Barcelona) has identified the genes involved in the latent asymptomatic state of breast cancer metastases. The work sheds light ...

Boosting cancer therapy with cross-dressed immune cells

January 22, 2018
Researchers at EPFL have created artificial molecules that can help the immune system to recognize and attack cancer tumors. The study is published in Nature Methods.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.